ArticlesCampaign to Reduce the Coprescribing of Opioids With Other Risky Drugs a Success and a FailureThe Back Letter 38(6):p 65, June 2023. | DOI: 10.1097/01.BACK.0000937392.83985.6f Buy Metrics © 2023 Wolters Kluwer Health, Inc. All rights reserved.